The relationship between symptomatic remission and neuropsychological improvement in schizophrenia patients switched to treatment with ziprasidone

This publication has 26 references indexed in Scilit:

• Should the CATIE Study Be a Wake-up Call?
  Psychiatric Services, 2005
• What does the PANSS mean?
  Schizophrenia Research, 2005
• Cognitive Remediation and Vocational Rehabilitation for Schizophrenia
  Schizophrenia Bulletin, 2005
• Cognitive Training and Supported Employment for Persons With Severe Mental Illness: One-Year Results From a Randomized Controlled Trial
  Schizophrenia Bulletin, 2005
• Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection
  Schizophrenia Research, 2005
• Sustained Remission of Schizophrenia
  American Journal of Psychiatry, 2005
• A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia
  Schizophrenia Bulletin, 2005
• Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia
  Schizophrenia Research, 2004
• Review of The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation.
  Contemporary Psychology, 1986
• A New Depression Scale Designed to be Sensitive to Change
  The British Journal of Psychiatry, 1979